AMERISAFE (NASDAQ:AMSF) Stock Price Target Cut by Citizens Jmp

AMERISAFE (NASDAQ:AMSF) had its price objective lowered by analysts at Citizens Jmp from $42.00 to $40.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “market outperform” rating on the insurance provider’s stock. Citizens Jmp’s price target points to a potential upside of 62.27% from the company’s current price.

Several other analysts have also recently commented on the company. Citigroup restated a “market outperform” rating on shares of AMERISAFE in a research report on Monday. Zacks Research upgraded AMERISAFE from a “strong sell” rating to a “hold” rating in a research report on Monday, September 28th. Morgan Stanley set a $40.00 price target on AMERISAFE in a research report on Monday. Weiss Ratings cut AMERISAFE from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, July 28th. Finally, Wall Street Zen raised AMERISAFE from a “sell” rating to a “hold” rating in a report on Monday. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $35.67.

AMERISAFE Trading Down 1.2%

Shares of NASDAQ:AMSF opened at $24.65 on Monday. The firm’s 50 day moving average is $25.57 and its two-hundred day moving average is $29.75. AMERISAFE has a 52 week low of $23.20 and a 52 week high of $42.22. The firm has a market capitalization of $457.01 million, a P/E ratio of 12.48 and a beta of 0.24.

AMERISAFE (NASDAQ:AMSF) last released its quarterly earnings results on Tuesday, July 21st. The insurance provider reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.08). The business had revenue of $91.97 million for the quarter, compared to the consensus estimate of $85.09 million. AMERISAFE had a net margin of 14.00% and a return on equity of 14.87%. Analysts predict that AMERISAFE will post 1.97 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Versant Capital Management Inc raised its holdings in AMERISAFE by 978.4% during the third quarter. Versant Capital Management Inc now owns 1,650 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 1,497 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in AMERISAFE in the second quarter worth approximately $411,000. Integrated Wealth Concepts LLC bought a new position in AMERISAFE during the 2nd quarter valued at $50,000. Squarepoint Ops LLC boosted its stake in AMERISAFE by 56.2% during the 2nd quarter. Squarepoint Ops LLC now owns 27,654 shares of the insurance provider’s stock valued at $936,000 after purchasing an additional 9,949 shares in the last quarter. Finally, Allworth Financial LP boosted its stake in AMERISAFE by 317.8% during the 2nd quarter. Allworth Financial LP now owns 1,124 shares of the insurance provider’s stock valued at $38,000 after purchasing an additional 855 shares in the last quarter. 97.41% of the stock is currently owned by institutional investors.

AMERISAFE News Roundup

Here are the key news stories impacting AMERISAFE this week:

• Positive Sentiment: Citizens JMP maintained a “market outperform” rating on AMERISAFE while trimming its price target to $40 from $42. The revised target still implies substantial upside from recent trading levels. AMERISAFE Stock Gets Price Target Trim from Citizens JMP
• Positive Sentiment: Analysts’ consensus price target was reported at $44, suggesting expectations for meaningful appreciation despite recent weakness. AMERISAFE Consensus Target Price
• Neutral Sentiment: Wall Street Zen upgraded AMERISAFE to “hold,” indicating a more balanced view rather than a strong bullish or bearish recommendation. AMERISAFE Upgraded to Hold
• Negative Sentiment: Truist lowered its price target sharply to $27 from $32 and retained a “hold” rating. Although the new target represents approximately 9.5% potential upside, the cut signals reduced near-term expectations and is the clearest negative catalyst for the stock. Truist Adjusts Price Target on AMERISAFE

About AMERISAFE

AMERISAFE, Inc (NASDAQ: AMSF) is a specialty workers’ compensation insurance company serving small and midsize employers in industries with elevated workplace risks. The company provides coverage designed to help businesses manage the costs associated with work-related injuries and occupational illnesses.

Its primary markets include construction, trucking, logging, agriculture, maritime operations, oil and gas, and other hazardous industries. In addition to insurance coverage, AMERISAFE emphasizes workplace safety, risk management, claims handling and return-to-work support to help policyholders reduce accidents and manage employee injuries.

Headquartered in DeRidder, Louisiana, AMERISAFE has historically focused on selected U.S.